SCC-话题@MedSci

#SCC#

58篇内容 | 970人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1987649, encodeId=5fdc198e649d9, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法, objectType=article, longId=94071, objectId=2032940e105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2032940e105, replyNumber=0, likeNumber=46, createdTime=2017-09-17, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2032940e105, moduleTitle=百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2032940e105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987645, encodeId=a3bc198e6451a, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, objectType=article, longId=76273, objectId=3d4be6273e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4be6273e6, replyNumber=0, likeNumber=18, createdTime=2017-05-08, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4be6273e6, moduleTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4be6273e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987646, encodeId=4826198e6466a, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=2016MASCC/ESMO共识建议——放疗相关恶心呕吐的预防发布, objectType=article, longId=78089, objectId=2cabe808940, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cabe808940, replyNumber=0, likeNumber=22, createdTime=2017-06-22, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cabe808940, moduleTitle=2016MASCC/ESMO共识建议——放疗相关恶心呕吐的预防发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cabe808940)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987644, encodeId=ad7e198e64433, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=2016MASCC/ESMO共识建议——晚期肿瘤恶心呕吐的管理发布, objectType=article, longId=75736, objectId=204be57367b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=204be57367b, replyNumber=0, likeNumber=22, createdTime=2017-05-16, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=204be57367b, moduleTitle=2016MASCC/ESMO共识建议——晚期肿瘤恶心呕吐的管理发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=204be57367b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987647, encodeId=0674198e6472e, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=2016MASCC/ESMO指南——放化疗相关性恶心呕吐以及晚期肿瘤患者恶心呕吐的预防发布, objectType=article, longId=78691, objectId=2fcce8691d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fcce8691d2, replyNumber=0, likeNumber=24, createdTime=2017-02-16, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fcce8691d2, moduleTitle=2016MASCC/ESMO指南——放化疗相关性恶心呕吐以及晚期肿瘤患者恶心呕吐的预防发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fcce8691d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987641, encodeId=c382198e6416a, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=百时美PD-1免疫疗法Opdivo关键III期临床治疗头颈部鳞状细胞癌（SCCHN）大获成功, objectType=article, longId=66959, objectId=0eb56695937, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0eb56695937, replyNumber=0, likeNumber=49, createdTime=2016-11-03, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0eb56695937, moduleTitle=百时美PD-1免疫疗法Opdivo关键III期临床治疗头颈部鳞状细胞癌（SCCHN）大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eb56695937)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987643, encodeId=961f198e64353, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=2016MASCC/ESMO共识建议——中度致吐化疗恶心呕吐的治疗发布, objectType=article, longId=75277, objectId=f7a5e527789, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7a5e527789, replyNumber=0, likeNumber=16, createdTime=2017-05-03, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7a5e527789, moduleTitle=2016MASCC/ESMO共识建议——中度致吐化疗恶心呕吐的治疗发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7a5e527789)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987642, encodeId=755d198e642ca, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=2016MASCC/ESMO共识建议——高催吐风险化疗恶心呕吐的预防（更新）发布, objectType=article, longId=73707, objectId=e887e37075c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e887e37075c, replyNumber=0, likeNumber=24, createdTime=2016-09-14, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e887e37075c, moduleTitle=2016MASCC/ESMO共识建议——高催吐风险化疗恶心呕吐的预防（更新）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e887e37075c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987648, encodeId=4f32198e64811, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=2016SCCM/ASHP/ACCP临床实践指南：维持成人危重患者神经肌肉阻滞发布, objectType=article, longId=80564, objectId=0a3e8056443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a3e8056443, replyNumber=0, likeNumber=15, createdTime=2017-06-01, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a3e8056443, moduleTitle=2016SCCM/ASHP/ACCP临床实践指南：维持成人危重患者神经肌肉阻滞发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a3e8056443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987640, encodeId=fb03198e640dc, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=【干货】HPV可否成为宫颈癌筛查**方案（全新宫颈癌筛查攻略：ASCCP/SGO会议纪要）, objectType=article, longId=60988, objectId=b9f96098857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9f96098857, replyNumber=0, likeNumber=36, createdTime=2016-11-17, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9f96098857, moduleTitle=【干货】HPV可否成为宫颈癌筛查**方案（全新宫颈癌筛查攻略：ASCCP/SGO会议纪要）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9f96098857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987639, encodeId=8dfb198e639db, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=IJRO（Red）：EPO不能提高贫血HNSCC患者放化疗的局控率, objectType=article, longId=49055, objectId=0f9749055d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f9749055d7, replyNumber=0, likeNumber=42, createdTime=2015-09-24, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f9749055d7, moduleTitle=IJRO（Red）：EPO不能提高贫血HNSCC患者放化疗的局控率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f9749055d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987638, encodeId=d4b5198e6383e, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=SCCT 2014：CCTA预测冠脉疾病患者生存或更佳, objectType=article, longId=37963, objectId=c73f3e96355, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c73f3e96355, replyNumber=0, likeNumber=35, createdTime=2014-12-29, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c73f3e96355, moduleTitle=SCCT 2014：CCTA预测冠脉疾病患者生存或更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c73f3e96355)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987636, encodeId=087a198e6365e, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=SCC 2014：我国迫切需要制定心血管病防治战略规划, objectType=article, longId=33739, objectId=9fc333e3979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fc333e3979, replyNumber=0, likeNumber=47, createdTime=2014-05-08, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fc333e3979, moduleTitle=SCC 2014：我国迫切需要制定心血管病防治战略规划, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fc333e3979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987637, encodeId=0ecd198e63757, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=SCCT 2014：CT血管造影结果支持2013 ACC/AHA指南, objectType=article, longId=37962, objectId=875b3e962b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875b3e962b2, replyNumber=0, likeNumber=45, createdTime=2015-06-12, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875b3e962b2, moduleTitle=SCCT 2014：CT血管造影结果支持2013 ACC/AHA指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=875b3e962b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987634, encodeId=1670198e63438, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=ASCCP更新2013年宫颈癌筛查指南, objectType=article, longId=28907, objectId=27dc2890ebf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27dc2890ebf, replyNumber=0, likeNumber=32, createdTime=2014-01-12, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27dc2890ebf, moduleTitle=ASCCP更新2013年宫颈癌筛查指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27dc2890ebf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987635, encodeId=5474198e63509, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=SCCA推荐50岁起定期筛查结肠癌, objectType=article, longId=32365, objectId=474f323652d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=474f323652d, replyNumber=0, likeNumber=44, createdTime=2014-10-01, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=474f323652d, moduleTitle=SCCA推荐50岁起定期筛查结肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=474f323652d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987633, encodeId=400e198e63377, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=CCR7预示SCC颈部淋巴结转移, objectType=article, longId=9931, objectId=995299319b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=995299319b, replyNumber=0, likeNumber=32, createdTime=2013-02-26, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=995299319b, moduleTitle=CCR7预示SCC颈部淋巴结转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=995299319b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987632, encodeId=5737198e632a5, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, objectTitle=SCC2011:肥厚型心肌病的现状与展望, objectType=article, longId=2582, objectId=b38e25826b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b38e25826b, replyNumber=0, likeNumber=35, createdTime=2012-02-16, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b38e25826b, moduleTitle=SCC2011:肥厚型心肌病的现状与展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b38e25826b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SCC

2020-05-29

zutt (审核中...)

前往app查看评论内容

#SCC#

百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法

2017-09-17

zutt (审核中...)

前往app查看评论内容

#SCC#

2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布

2017-05-08

zutt (审核中...)

前往app查看评论内容

#SCC#

2016MASCC/ESMO共识建议——放疗相关恶心呕吐的预防发布

2017-06-22

zutt (审核中...)

前往app查看评论内容

#SCC#

2016MASCC/ESMO共识建议——晚期肿瘤恶心呕吐的管理发布

2017-05-16

zutt (审核中...)

前往app查看评论内容

#SCC#

2016MASCC/ESMO指南——放化疗相关性恶心呕吐以及晚期肿瘤患者恶心呕吐的预防发布

2017-02-16

zutt (审核中...)

前往app查看评论内容

#SCC#

百时美PD-1免疫疗法Opdivo关键III期临床治疗头颈部鳞状细胞癌（SCCHN）大获成功

2016-11-03

zutt (审核中...)

前往app查看评论内容

#SCC#

2016MASCC/ESMO共识建议——中度致吐化疗恶心呕吐的治疗发布

2017-05-03

zutt (审核中...)

前往app查看评论内容

#SCC#

2016MASCC/ESMO共识建议——高催吐风险化疗恶心呕吐的预防（更新）发布

2016-09-14

zutt (审核中...)

前往app查看评论内容

#SCC#

2016SCCM/ASHP/ACCP临床实践指南：维持成人危重患者神经肌肉阻滞发布

2017-06-01

zutt (审核中...)

前往app查看评论内容

#SCC#

【干货】HPV可否成为宫颈癌筛查**方案（全新宫颈癌筛查攻略：ASCCP/SGO会议纪要）

2016-11-17

zutt (审核中...)

前往app查看评论内容

#SCC#

IJRO（Red）：EPO不能提高贫血HNSCC患者放化疗的局控率

2015-09-24

zutt (审核中...)

前往app查看评论内容

#SCC#

SCCT 2014：CCTA预测冠脉疾病患者生存或更佳

2014-12-29

zutt (审核中...)

前往app查看评论内容

#SCC#

SCC 2014：我国迫切需要制定心血管病防治战略规划

2014-05-08

zutt (审核中...)

前往app查看评论内容

#SCC#

SCCT 2014：CT血管造影结果支持2013 ACC/AHA指南

2015-06-12

zutt (审核中...)

前往app查看评论内容

#SCC#

ASCCP更新2013年宫颈癌筛查指南

2014-01-12

zutt (审核中...)

前往app查看评论内容

#SCC#

SCCA推荐50岁起定期筛查结肠癌

2014-10-01

zutt (审核中...)

前往app查看评论内容

#SCC#

CCR7预示SCC颈部淋巴结转移

2013-02-26

zutt (审核中...)

前往app查看评论内容

#SCC#

SCC2011:肥厚型心肌病的现状与展望

2012-02-16

科室
- - 订阅+
  - 更多科室
工具
服务